Related Experiment Videos

LXRs: new therapeutic targets in atherosclerosis?

Sean B Joseph1, Peter Tontonoz

  • 1Howard Hughes Medical Institute, Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA 90095-1662, USA.

Insights

Liver X receptors (LXRs), activated by oxysterols, regulate lipid metabolism. LXR activity is linked to atherosclerosis, making the LXR pathway a potential target for cardiovascular disease intervention.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Metabolic Disease Research

Background:

  • Liver X receptors (LXRs) are oxysterol-activated nuclear receptors crucial for lipid homeostasis.
  • LXRs regulate cholesterol and fatty acid metabolism in key tissues like the liver, intestine, and macrophages.
  • Dysregulation of LXR activity is implicated in metabolic disorders, including hyperlipidemia and atherosclerosis.

Purpose of the Study:

  • To investigate the role of liver X receptors (LXRs) in lipid metabolism and their connection to metabolic disorders.
  • To explore the potential of targeting the LXR pathway for cardiovascular disease intervention.

Main Methods:

  • This study reviews existing research on LXR function and its involvement in lipid metabolism.
  • Analysis of recent studies linking LXR activity to the pathogenesis of atherosclerosis.

Main Results:

  • LXRs play a significant role in controlling lipid homeostasis across multiple tissues.
  • Evidence directly links LXR activity to the development of atherosclerosis.
  • The LXR pathway is implicated in the progression of hyperlipidemia.

Conclusions:

  • The LXR pathway is a key regulator of physiological lipid metabolism.
  • LXR activity is directly involved in the pathogenesis of atherosclerosis.
  • Targeting the LXR pathway presents a promising strategy for treating cardiovascular diseases.

Related Concept Videos